The market growth can be attributed to several factors such as increasing prevalence of neuroblastoma in children, improvements in the healthcare infrastructure, and rising R&D activities are anticipated to further contribute to this substantial market growth between 2019 and 2030. However, high cost of this therapy is likely to restrain the growth of market to a certain extent.
Market Industry Reports (MIR) has published a new report titled “Pediatric Neuroblastoma Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the Global Pediatric Neuroblastoma Treatment Market is estimated to account for over US$ 676.0 million by 2019. The market is anticipated to grow at a CAGR of ~8.6% from 2019 to 2030.
Get sample copy of “Pediatric Neuroblastoma Treatment Market” at: https://www.marketindustryreports.com/pdf/225
Some of the prominent players in the Pediatric Neuroblastoma Treatment Market include:
To obtain better insights regarding the market scenario, prominent players are increasingly focusing on collaborative initiatives with several institutes, research centers, and companies. For instance, In January 2020, EUSA Pharma and BeiGene, Ltd. announced that they have entered into an exclusive development and commercialization agreement for the orphan biologic products SYLVANT (siltuximab) and QARZIBA (dinutuximab beta) in Greater China.
According to the American Society of Clinical Oncology (ASCO), in U.S., neuroblastoma is the 3rd most common cancer found in children, accounting for more than 6% of childhood cancer and nearly 800 new cases of neuroblastoma are reported in the U.S. each year. Therefore, the rising incidences of pediatric neuroblastoma can be a major factor contributing to the growth of market.
The Pediatric Neuroblastoma Treatment Market is segmented on the basis of Product, Modality, Cancer Type, End-Users and region.
By Treatment Type:
Immunotherapy, Chemotherapy, and Radiation Therapy
Low Risk, Intermediate Risk and High Risk)
Hospitals and Cancer Specialty Centers
As a standard protocol at MIR, all research assignments go through the following rigorous processes.
- Secondary Research
- Primary Research
- Market Size Estimation & Forecasting
- Data Validation & Triangulation
- Report Generation
Have any query? Inquiry about report: https://www.marketindustryreports.com/inquiry/225
Table of Contents
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2017 & 2018; Base Year – 2019; Forecasted Years – 2020 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Data Validation and Triangulation
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
Buy this report @ https://www.marketindustryreports.com/checkout/225
About Market Industry Reports
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Phone: + 91 8956767535